303 related articles for article (PubMed ID: 16273544)
21. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
22. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia.
Notterpek L; Roux KJ; Amici SA; Yazdanpour A; Rahner C; Fletcher BS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14404-9. PubMed ID: 11717414
[TBL] [Abstract][Full Text] [Related]
23. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
[TBL] [Abstract][Full Text] [Related]
24. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
[TBL] [Abstract][Full Text] [Related]
25. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
26. Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice.
Amici SA; Dunn WA; Notterpek L
J Neurosci Res; 2007 Feb; 85(2):238-49. PubMed ID: 17131416
[TBL] [Abstract][Full Text] [Related]
27. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
Berger P; Niemann A; Suter U
Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
[TBL] [Abstract][Full Text] [Related]
28. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
29. Charcot-Marie-Tooth disease and related peripheral neuropathies.
De Jonghe P; Timmerman V; Nelis E; Martin JJ; Van Broeckhoven C
J Peripher Nerv Syst; 1997; 2(4):370-87. PubMed ID: 10975746
[TBL] [Abstract][Full Text] [Related]
30. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
31. Compound heterozygous PMP22 deletion mutations causing severe Charcot-Marie-Tooth disease type 1.
Abe A; Nakamura K; Kato M; Numakura C; Honma T; Seiwa C; Shirahata E; Itoh A; Kishikawa Y; Hayasaka K
J Hum Genet; 2010 Nov; 55(11):771-3. PubMed ID: 20739940
[TBL] [Abstract][Full Text] [Related]
32. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
33. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations.
Ryan MC; Shooter EM; Notterpek L
Neurobiol Dis; 2002 Jul; 10(2):109-18. PubMed ID: 12127149
[TBL] [Abstract][Full Text] [Related]
34. Trembler mouse carries a point mutation in a myelin gene.
Suter U; Welcher AA; Ozcelik T; Snipes GJ; Kosaras B; Francke U; Billings-Gagliardi S; Sidman RL; Shooter EM
Nature; 1992 Mar; 356(6366):241-4. PubMed ID: 1552943
[TBL] [Abstract][Full Text] [Related]
35. Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploidy.
Ohnishi A; Li LY; Fukushima Y; Mori T; Mori M; Endo C; Yoshimura T; Sonobe M; Flandermeyer R; Lebo RV
Am J Med Genet; 1995 Oct; 59(1):51-8. PubMed ID: 8849012
[TBL] [Abstract][Full Text] [Related]
36. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene.
Gabreëls-Festen A; Wetering RV
Ann N Y Acad Sci; 1999 Sep; 883():336-43. PubMed ID: 10586258
[TBL] [Abstract][Full Text] [Related]
37. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies.
Naef R; Adlkofer K; Lescher B; Suter U
Mol Cell Neurosci; 1997 Jan; 9(1):13-25. PubMed ID: 9204477
[TBL] [Abstract][Full Text] [Related]
38. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1.
Numakura C; Lin C; Oka N; Akiguchi I; Hayasaka K
Ann Neurol; 2000 Jan; 47(1):101-3. PubMed ID: 10632107
[TBL] [Abstract][Full Text] [Related]
39. An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration.
Orfali W; Nicholson RN; Guiot MC; Peterson AC; Snipes GJ
J Neurosci Res; 2005 Apr; 80(1):37-46. PubMed ID: 15723356
[TBL] [Abstract][Full Text] [Related]
40. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
Müller HW
Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
